Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,498.55 -3.10 -0.02%
S&P 500 1,878.75 3.36 0.18%
NASDAQ 4,147.85 20.88 0.51%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,404.99 -141.28 -0.97%
TOPIX 1,164.90 -8.91 -0.76%
HANG SENG 22,562.80 53.16 0.24%

Anatabloc® Face Serum Launch Continues: Product Now Available at GNC



     Anatabloc® Face Serum Launch Continues: Product Now Available at GNC

PR Newswire

GLEN ALLEN, Va., April 30, 2013

GLEN ALLEN, Va., April 30, 2013 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ:
STSI) announced today that the Company's second cosmetic product, Anatabloc®
Revitalizing Facial Serum, is now available for sale on GNC's website
(www.GNC.com).  The product was launched last month on the Anatabloc® skincare
website (http://skincare.anatabloc.com/).  GNC began carrying the Company's
first cosmetic product, Anatabloc® Facial Creme, on its website in February of
this year.

(Photo: http://photos.prnewswire.com/prnh/20130430/PH04135 )
(Logo: http://photos.prnewswire.com/prnh/20130319/PH79245LOGO )

The Anatabloc® serum is specifically formulated to penetrate the skin and
target specific skin concerns, including, wrinkles, firming, age spots, and
discolorations.  Regular application of the serum can significantly improve
the appearance of the skin. The serum is designed to be used prior to the
application of Anatabloc® Rare Cellular Facial Creme. 

David Dean, Star Scientific's Vice President for Sales and Marketing, stated,
"We are proud to have an expanded presence in the GNC system, with all four of
our Anatabloc® products being offered to consumers.  Anatabloc® Original can
be purchased in all GNC stores, and all of our products, Anatabloc® Original,
Anatabloc® Unflavored, the cream and the serum are available on GNC's
website. This is a great opportunity to increase our outreach to customers and
sales."

As previously reported, a multi-site clinical (human) dermatological study of
the Anatabloc® Facial Creme is underway to determine if the product is helpful
to individuals with mild to moderate rosacea. The clinical trial is being
supervised by Dr. Susan H. Weinkle of Bradenton, Florida, an experienced and
respected practitioner and clinical investigator.  The other two investigators
are leading dermatologists, Dr. Mary Lupo of New Orleans, Louisiana, and Dr.
Diane Berson of New York City, NY.  As of today, the study has enrolled over
100 subjects and screening is now closed. 

Certain statements contained in this release constitute forward-looking
statements within the meaning of the Private Securities Litigation Reform Act
of 1995. Such statements include, but are not limited to statements identified
by words such as "believes," "expects," "anticipates," "estimates," "intends,"
"plans," "targets," "projects" and similar expressions. The statements in this
release are based upon the current beliefs and expectations of our company's
management and are subject to significant risks and uncertainties. Actual
results may differ from those set forth in the forward-looking statements.
Numerous factors could cause or contribute to such differences, including, but
not limited to, results of clinical trials and/or other studies, the
challenges inherent in new product development initiatives, including the
continued development and market acceptance of our nutraceutical dietary
supplements products, the effect of any competitive products, our ability to
license and protect our intellectual property, our ability to raise additional
capital in the future that is necessary to maintain our business, changes in
government policy and/or regulation, potential litigation by or against us and
any governmental review of our products or practices, as well as other risks
discussed from time to time in our filings with the Securities and Exchange
Commission, including, without limitation, our annual report on Form 10-K for
the fiscal year ended December 31, 2012. We undertake no duty to update any
forward-looking statement or any information contained in this press release
or in other public disclosures at any time.

About Star Scientific
Star Scientific, Inc. is a technology-oriented company with a mission to
promote maintenance of a healthy metabolism and lifestyle. Through its wholly
owned subsidiary, Rock Creek Pharmaceuticals, Star Scientific has been engaged
in the manufacturing, sale, and marketing of two nutraceutical dietary
supplements, a cosmetic facial cream, and the development of other
nutraceuticals and pharmaceuticals. The company also continues to pursue the
licensing of the technology behind its proprietary StarCured® curing process
and its related products. Rock Creek Pharmaceuticals has scientific and
research offices in Gloucester, MA, and a regulatory office in Washington, DC.
Star Scientific has a Corporate and Sales Office in Glen Allen, VA, and an
Executive, Scientific & Regulatory Affairs office in Washington, DC.

Contact:
Talhia T. Tuck
Vice President, Communications and Investor Relations
Star Scientific, Inc.
(202)887-5100
ttuck@starscientific.com

SOURCE Star Scientific, Inc.

Website: http://www.starscientific.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement